INDIAN PHARMACEUTICAL ALLIANCE(FORMERLY INDIAN PHARMACEUTICAL ASSOCIATION)

IPA champions a U.S.-India affordable medicine trade partnership to drive national security and de-risk the affordable medicine supply chain, including Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). This initiative aims to extend to other trusted allies, enhancing global supply chain resilience.

IPA champions a U.S.-India trade partnership to de-risk the affordable medicine supply chain, including Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). This initiative aims to extend to other trusted allies, enhancing global supply chain resilience. The partnership focuses on industry sustainability, quality metrics, market demand, and boosting domestic and allied manufacturing with a suite of financial tools

IPA champions a U.S.-India trade partnership to drive national security and de-risk the affordable medicine supply chain, including Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). This initiative aims to extend to other trusted allies, enhancing global supply chain resilience.

IPA seeks to establish a U.S.-India trade partnership to de-risk the affordable medicine supply chain, including Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). This initiative aims to extend to other trusted allies, enhancing global supply chain resilience. The partnership focuses on industry sustainability, quality metrics, market demand, and boosting domestic and allied manufacturing with a suite of financial tools. Additionally, IPA seeks to advocate for middlemen reform and sustainability in the pharmaceutical sector, ensuring long-term viability and accessibility of affordable medicines.

IPA is dedicated to advancing and resolving critical issues that impact the generic medicine sector with a focus on the primary three areas: Healthcare Policy: IPA actively works to influence health policy reforms that promote access to affordable medicines and support public health goals. This includes advocating for policies that ensure patient access to affordable medications through necessary reforms of the Hatch-Waxman Act: mantaining a balance between fostering brand innovation and timely entry of generics. Also, IPA actively seeks to establish a U.S.-India partnership focused on affordable medicine,partnership aims to enhance supply chain resiliency and national security.